CJM-112
Product Specifications
Target
Interleukin
Related Pathways
Immunology/Inflammation
Bioactivity
CJM-112 is a humanized monoclonal antibody inhibitor that targets interleukin-17A (IL-17A) . It holds potential for research in inflammatory diseases, such as hidradenitis suppurativa, which involve abnormalities in the IL-17A-related pathway.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
RG-E141453-01 10 mg
(Z) -4- ((2-ethyl-4-methylpentyl) oxy) -4-oxobut-2-enoic acid
Sign In for Pricing
View Details 
RG-E141453-02 100 mg
(Z) -4- ((2-ethyl-4-methylpentyl) oxy) -4-oxobut-2-enoic acid
Sign In for Pricing
View Details 
RG-E141453-03 25 mg
(Z) -4- ((2-ethyl-4-methylpentyl) oxy) -4-oxobut-2-enoic acid
Sign In for Pricing
View Details RG-E141453-04 50 mg
(Z) -4- ((2-ethyl-4-methylpentyl) oxy) -4-oxobut-2-enoic acid
Sign In for Pricing
View Details MBS745710-01 48 Well
Porcine Retinoic acid induced protein 3 ELISA Kit
Sign In for Pricing
View Details MBS745710-02 96 Well
Porcine Retinoic acid induced protein 3 ELISA Kit
Sign In for Pricing
View Details